milliporesigma videos
-
Bio4C ProcessPad™ Product Overview
5/19/2020
Introducing Bio4C ProcessPad™ Software, part of the BioContinuum™ Platform.
-
The Facility Of The Future
5/19/2020
The facility of the future requires evolution in many disciplines by combining advanced bioprocessing and digital technologies under one roof. Welcome to bioprocessing 4.0.
-
Welcome To The World Of Innovation
5/19/2020
Curiosity, science and innovation are at the heart of everything we do. We are pioneers shaping the future of manufacturing. Every day we are pushing boundaries, collaboratively working on disruptive, digitally-enhanced and model driven bioprocessing technologies through an innovative platform converging digital and advanced processing tools. We empower biomanufacturers to confidently enter the era of bioprocessing 4.0. This holistic solution will accelerate the transformation to the data-driven revolution.
-
Strategies To Reduce Regulatory Risks In Gene Therapy
5/15/2020
Learn how to mitigate regulatory risk for your gene therapy process.
-
Selecting The Right CMO For Your Gene Therapy
5/15/2020
Find out what criteria makes a great CMO partner and how to know if it is the right one for your gene therapy.
-
Single-pass Tangential Flow Filtration For Bioprocessing
4/2/2020
Experiencing bottlenecks in your downstream process? Pellicon® Single-Pass TFF increases your productivity, capacity while reducing costs!
-
Concentrate Your Product After One Path With Pellicon® Single Pass Tangential Flow Filtration
4/2/2020
Discover Pellicon® Single-Pass Tangential Flow Filtration, the versatile ultrafiltration technology for process intensification.
-
Making Data Work
12/16/2019
What is big data? What is Bioprocess 4.0? How do you leverage data to make better informed decisions? This video explores the role data plays in biopharma scale-up and manufacturing. Learn how to make data work for you.
-
Reduce The Level Of Host Cell Protein In The Bioreactor Harvest
12/11/2019
Host cell proteins (HCPs) are an inevitable byproduct of biologics manufacturing and can have an impact on product quality and efficacy as well as patient safety. Processes designed to remove HCPs from the bioreactor harvest must not only be successful in achieving acceptable limits, but also be scalable. Learn how we helped our client reduce the level of HCPs in the bioreactor harvest prior to a production run to supply drug substance for a scheduled Phase 1 clinical trial in a very tight timeline.
-
Optimize The Formulation Of A Monoclonal Antibody
12/11/2019
You have a molecule of interest and need an effective formulation to maximize stability and minimize aggregation. As with all formulations, it is essential that the buffers and excipients ensure stability of the drug substance, be compatible with each other and meet regulatory requirements. An emerging biotech company sought our help in developing a formulation for a monoclonal antibody. Learn how we have delivered an optimized formulation for this customer in three months.